search
Back to results

The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.

Primary Purpose

Hypertension

Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Amlodipine and Hydrocholorothiazide
Sponsored by
University of New Mexico
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • mild hypertension and high cholesterol

Exclusion Criteria:

  • diabetes and heart disease

Sites / Locations

  • UNMHSC

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

1

2

Arm Description

Amlodipine

HCTZ

Outcomes

Primary Outcome Measures

PAI-1

Secondary Outcome Measures

Full Information

First Posted
April 7, 2008
Last Updated
July 7, 2023
Sponsor
University of New Mexico
search

1. Study Identification

Unique Protocol Identification Number
NCT00656331
Brief Title
The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.
Official Title
The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications: A Comparison of Amlodipine and Hydrochlorothiazide
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Withdrawn
Study Start Date
August 2005 (undefined)
Primary Completion Date
June 2012 (Actual)
Study Completion Date
June 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of New Mexico

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to compare the effects of the cholesterol medication taken with each blood pressure medication alone on heart disease risk factors including blood pressure, cholesterol, inflammation, blood sugar control, blood vessal function, and other heart disease risk factors.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
Amlodipine
Arm Title
2
Arm Type
Active Comparator
Arm Description
HCTZ
Intervention Type
Drug
Intervention Name(s)
Amlodipine and Hydrocholorothiazide
Intervention Description
Arm 1 gets Amlodipine and Arm 2 gets Hydrocholorothiazide
Primary Outcome Measure Information:
Title
PAI-1
Time Frame
study completion

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: mild hypertension and high cholesterol Exclusion Criteria: diabetes and heart disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kathleen Colleran, MD
Organizational Affiliation
University of New Mexico
Official's Role
Principal Investigator
Facility Information:
Facility Name
UNMHSC
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87131
Country
United States

12. IPD Sharing Statement

Learn more about this trial

The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.

We'll reach out to this number within 24 hrs